Project description:We report the application of size selection of small RNA species isolated from Jjhan cells harboring the human herpesvirus 6A genome. We ammassed >3.4million reads of sequence from three different sources: Normal Brain cell total RNA, Jjhan total RNA and HHV-6A BAC transfected Jjhan total RNA. Sequences were mapped to the HHV-6A Uganda 1102 strain genome (GenBank: X83413.1) with no less than 100% match for reads >20nt and <23nt. The resulting pool of candidates was mapped to the HHV-6A genome. Single pass 36nt sequencing of samples either with or without HHV-6a genomes present.
Project description:We report the application of size selection of small RNA species isolated from Jjhan cells harboring the human herpesvirus 6A genome. We ammassed >3.4million reads of sequence from three different sources: Normal Brain cell total RNA, Jjhan total RNA and HHV-6A BAC transfected Jjhan total RNA. Sequences were mapped to the HHV-6A Uganda 1102 strain genome (GenBank: X83413.1) with no less than 100% match for reads >20nt and <23nt. The resulting pool of candidates was mapped to the HHV-6A genome.
Project description:To determine if HHV-6A infection affects cell metabolism of host cells, we conducted a global RNA sequencing analysis in HHV-6A infected cells
Project description:In order to understand the effect of HHV-6A reactivation on host cell, U2-OS bone osteosarcoma cells were generated carrying latent HHV-6A genome. These cells were either treated with DMSO (solvent control) or Trichostatin-A (TSA) for viral reactivation. As a control cells carrying no HHV-6A were used and treated similarly. Two biological replicates of each sample were processed for small RNA transcriptomics (small RNAseq). Furthermore, HeLa (cervical epithelial cells) were generated carrying lentiviral insertions of one of the small non-coding RNA from HHV-6A (sncRNA-U14). These cells could be transiently induced for sncRNA-U14 transcription using Doxycycline. HeLa cells having a mock lentiviral backbone was used as a control and was treated similarly. Two biological replicates of each sample were processed for small RNA transcriptomics (small RNAseq).
Project description:Purpose: The RF/6A chorioretinal cell line originally isolated from a fetal rhesus macaque in 1968 is widely used to model human retinal and choroidal endothelial cells in cell culture. We sought to determine the extent to which this line possesses endothelial cell-specific characteristics. Methods: RF/6A cells obtained from American Type Culture Collection were subjected to next-generation RNA sequencing. Transcriptomic-based cell type profiling was conducted using xCell. Validation of endothelial cell-specific marker expression was conducted by qRT-PCR and western blotting. Functional assays of acetylated low density lipoprotein uptake, TNF-?-induced adhesion molecule expression, shear stress alignment, and endothelial tube formation were assessed. Results: RF/6A transcriptomic profiles obtained de novo or from a publically available repository did not correspond to endothelial gene expression signatures. Expression of established endothelial markers (PECAM1, CDH5, KDR, VWF, ICAM2, ENG, or TEK) were very low or undetectable in RF/6A compared to primary human umbilical vein endothelial cells. Compared to primary endothelial cells, RF/6A were unable to uptake acetylated LDL, exhibit induction of E-selectin in response to TNF-? treatment, align in the direction of shear stress, or form regular capillary-like tubes in Matrigel. Conclusions: RF/6A do not exhibit key endothelial cell characteristics or behaviors. Therefore, caution should be employed in designing and interpreting studies using these cells as surrogates for choroidal or retinal endothelial cells.